Thrill Pharma HELIOUS

HELIOS

HELIOS is a precision-targeted fat loss injectable that combines two complementary lipolytic agents — Clenbuterol HCl and Yohimbine HCl — into a single subcutaneous administration formula. Clenbuterol, a beta-2 adrenergic agonist, elevates core body temperature and resting metabolic rate through thermogenesis, stimulates fat cell lipolysis, and preserves lean muscle tissue during caloric restriction.

Yohimbine HCl adds a powerful complementary mechanism: as an alpha-2 adrenergic receptor antagonist, it blocks the receptor subtype that actively inhibits fat breakdown in stubborn, hard-to-lose adipose regions — particularly the lower abdomen, hips, and thighs. By disabling this inhibitory mechanism, Yohimbine allows lipolysis to proceed unimpeded in areas that are otherwise resistant to fat loss.

HELIOS is designed for athletes in the final stages of contest preparation or dedicated cutting cycles who require targeted elimination of stubborn subcutaneous fat deposits. It is most effective when administered subcutaneously near the target fat area before fasted cardiovascular exercise, maximising localised fat mobilisation and systemic thermogenic output simultaneously.

Disclaimer: Above mentioned information is for educational and reference purposes only. Consult a registered healthcare professional for a proper course of medication. These statements have not been evaluated by the Food and Drug Administration. This product shall only be available on a prescription from a registered healthcare professional.

Frequently Asked Questions